Abstract
The synthesis and structure-activity relationship (SAR) studies of the effect of varying the "A" group in a series of 5-(acetamidomethyl)oxazolidonone antibacterials (2) are described. Compounds 2 were principally prepared either by the six-step synthesis described previously (J. Med. Chem. 1989, 32, 1673) or by elaboration of the synthetic intermediate 2 (A = H) via electrophilic aromatic substitution or elaboration of the intermediate 2 (A = I) by transition metal catalyzed carbon-carbon bond-forming reactions. Antibacterial evaluation of compounds 2 with A = alkyl, ethenyl, ethynyl, hydroxyalkyl, aldo and keto, oximinoakyl, carboalkoxy, nitro, amino, halo and psi-halo, alkylthio, alkylsulfinyl, and alkysulfonyl against Staphylococcus aureus and Enterococcus faecalis led to the identification of several SAR trends. In several series of homologues (alkyl, ketyl, aximinoalkyl, amino, halo and psi-halo, and alkythio), antibacterial activity increased with increasing lipophilicity. But in series with where A is a substituent with a trior tetrasubstituted (substituent larger than H) quaternary atom attached directly to the aromatic ring (hydroxyalkyl, alkylsulfinyl, alkylsufonyl), the activity peaked at the member of the series wi...Continue Reading
Citations
May 1, 1996·Journal of Pharmaceutical and Biomedical Analysis·M Alasandro
Sep 1, 1992·Diagnostic Microbiology and Infectious Disease·W Brumfitt, J M Hamilton-Miller
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Michael B GravestockAlan Wookey
Apr 18, 2002·Bioorganic & Medicinal Chemistry Letters·Du Yu, Guo Huiyuan
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·M ArticoR Pompei
Nov 17, 2001·Bioorganic & Medicinal Chemistry·R G Karki, V M Kulkarni
Sep 15, 2010·Antimicrobial Agents and Chemotherapy·Jeffrey B LockeJeffrey L Stein
Apr 20, 2001·Chemical & Pharmaceutical Bulletin·R TokuyamaO Nagata
Feb 3, 2007·Chemical & Pharmaceutical Bulletin·Sunil Kumar Reddy AaramadakaMagesh Vijayan
Dec 24, 2011·Annals of the New York Academy of Sciences·Karen Joy Shaw, Michael R Barbachyn
Oct 1, 2014·Pharmacotherapy·Jeffrey M RybakCraig A Martin
Apr 20, 2005·Clinics in Chest Medicine·Richard J O'Brien, Mel Spigelman
Sep 1, 2004·Il Farmaco·Alessandra AmmazzalorsoMaria L Tricca
Sep 20, 2016·MedChemComm·Jesse A JonesKirk E Hevener
Oct 5, 2013·Clinical Microbiology Reviews·Michael J Pucci, Karen Bush
Jul 17, 2007·Chemical Biology & Drug Design·Jidong LiuWeicheng Zhou
Aug 3, 2001·The Journal of Biological Chemistry·U PatelE V Bobkova
Sep 6, 2013·Biological Chemistry·Jagmohan S SainiHolger Gohlke
Aug 23, 2002·Journal of Medicinal Chemistry·Natesan SelvakumarRamanujam Rajagopalan
Jan 8, 2003·The Journal of Organic Chemistry·Chan Sun ParkHyun-Joon Ha
Jan 8, 2003·The Journal of Organic Chemistry·Tae Bo SimHyun-Joon Ha
Oct 19, 2017·Organic Letters·Yasunori TodaHiroyuki Suga
Jan 17, 2015·Chemical Reviews·Valentine G NenajdenkoAleksey V Shastin
Aug 15, 2014·Chemical Reviews·Xiu-Hua XuNorio Shibata